Idelvion now registered in Australia

27 September 2016 - CSL Behring's Idelvion is now approved by the TGA. ...

Read more →

Zinbryta approved by TGA

27 September 2016 - The TGA has approved Biogen's Zinbryta. ...

Read more →

TGA approves new use for Takeda's Adcetris

27 September 2016 - The TGA has approved a new use for Takeda's CD 30 receptor antagonist. ...

Read more →

TGA approves Simponi for axial spondyloarthritis

15 September 2016 - The TGA has approved a new use for Simponi. ...

Read more →

TGA approves new indication for Alprolix

15 September 2016 - The TGA has approved a new use for Biogen's Alprolix. ...

Read more →

TGA approves Odefsey

30 August 2016 - The TGA has approved Gilead's combination product for HIV-1 infection Odefsey. ...

Read more →

TGA approves Taltz

14 September 2016 - The TGA has approved Eli Lilly's Taltz (ixekizumab). ...

Read more →

TGA approves new indication for Gazyva

5 September 2016 - The TGA has approved a new use for Roche's CD20 receptor antagonist. ...

Read more →

TGA approves new diagnostic agent

31 August 2016 - The TGA has approved Juno Pharmaceuticals' Hexvix. ...

Read more →

TGA approves Zepatier

31 August 2016 - The TGA has approved MSD's Zepatier (grazoprevir with elbasvir). ...

Read more →

TGA approves Briviact (brivaracetam)

12 August 2016 - The TGA has approved UCB's Briviact (brivaracetam). ...

Read more →

TGA approves Tagrisso (osimertinib mesylate)

12 August 2016 - The TGA has approved AstraZeneca's Tagrisso (osimertinib mesylate). ...

Read more →

TGA approves Afluria Quad

28 July 2016 - The TGA has approved CSL's Afluria Quad (quadrivalent influenza vaccine). ...

Read more →

TGA approves Brenzys (etanercept)

28 July 2016 - The TGA has approved a biosimilar to Pfizer's Enbrel. ...

Read more →

TGA approves Belkyra (deoxycholic acid)

28 July 2016 - The TGA has approved Allergan's Belkyra (deoxycholic acid). ...

Read more →